Phosphatidylinositol

It was initially called "inosite" when it was discovered by Léon Maquenne and Johann Joseph von Scherer in the late 19th century. It was discovered in bacteria but later also found in eukaryotes, and was found to be a signaling molecule.

Phosphatidylinositol

Depicting the Phosphatidylinisitol molecule with an overview of different segregated components; Inositol, Phosphate, Glycerol-backbone, sn-1 acyl chain, sn-2 acyl chain. Made by Mathias Sollie Sandsdalen in BioRender.com, modified from N.J. Blunsom and S. Cockcroft.
Names
IUPAC name [(2R)-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-2-octadecanoyloxypropyl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
Other names PI PtdIns
Identifiers
ChEBI	CHEBI:28874
DrugBank	DB02144
Properties
Chemical formula	C47H83O13P
Molar mass	887,104 g/mol, neutral with fatty acid composition - 18:0, 20:4
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Y verify (what is YN ?) Infobox references

The biomolecule can exist in 9 different isomers. It is a lipid which contains a phosphate group, two fatty acid chains, and one inositol sugar molecule. Typically, the phosphate group has a negative charge (at physiological pH values). As a result, the molecule is amphiphilic.

The production of the molecule is limited to the endoplasmic reticulum.

Phosphatidylinositol (PI) and its derivatives have a rich history dating back to their discovery by Johann Joseph von Scherer and Léon Maquenne in the late 19th century. Initially known as "inosite" based on its sweet taste, the isolation and characterization of inositol laid the groundwork for understanding its cyclohexanol structure. Théodore Posternak's work further elucidated the configuration of myo-inositol, the principal form found in eukaryotic tissues. The study of inositol isomers and their physiological functions has revealed a complex interplay in various organisms.

The esterified presence of inositol in lipids, particularly PI, was first observed in bacteria and later confirmed in eukaryotic organisms by researchers like Clinton Ballou and Dan Brown. Their pioneering work established the structure of PI and its phosphorylated forms, shedding light on their roles as signaling molecules. Despite the complexity of inositol nomenclature and isomerism, modern research has greatly advanced the understanding of their diverse functions in cellular physiology and signaling pathways.

The discovery of PI and its derivatives, along with their intricate roles in cellular signaling, marks a significant chapter in the field of biochemistry. From early investigations into inositol's structure to the identification of its various isomers and their physiological functions, the study of inositol compounds continues to uncover new insights into cellular processes.

Phosphatidylinositol (PI), also known as inositol phospholipid, is a lipid composed of a phosphate group, two fatty acid chains, and one inositol molecule. It belongs to the class of phosphatidylglycerides and is typically found as a minor component on the cytosolic side of eukaryotic cell membranes. The phosphate group imparts a negative charge to the molecules at physiological pH.

PI can exist in nine different forms, myo-, scyllo-, muco-, epi-, neo-, allo-, D-chiro-, L-chiro-, and cis-inositol. These isomers are common in biology and have many functions, for example taste sensory, regulating phosphate levels, metabolic flux, transcription, mRNA export and translation, insulin signaling, embryonic development and stress response. Cis-inositol is the only isomer not found naturally in nature.

PI exhibits an amphiphilic nature, with both polar and non-polar regions, due to its glycerophospholipid structure containing a glycerol backbone, two non-polar fatty acid tails, and a phosphate group substituted with an inositol polar head group.

Phosphorylated forms of phosphatidylinositol (PI) are called phosphoinositides and play important roles in lipid signaling, cell signaling and membrane trafficking. The inositol ring can be phosphorylated by a variety of kinases on the three, four and five hydroxyl groups in seven different combinations. However, the two and six hydroxyl groups are typically not phosphorylated due to steric hindrance.

All seven variations of the following phosphoinositides have been found in animals:

Phosphatidylinositol monophosphates:

• Phosphatidylinositol 3-phosphate, also known as PtdIns3P or PI(3)P
• Phosphatidylinositol 4-phosphate, also known as PtdIns4P or PI(4)P
• Phosphatidylinositol 5-phosphate, also known as PtdIns5P or PI(5)P

Phosphatidylinositol bisphosphates:

• Phosphatidylinositol 3,4-bisphosphate, also known as PtdIns(3,4)P₂ or PI(3,4)P₂
• Phosphatidylinositol 3,5-bisphosphate, also known as PtdIns(3,5)P₂ or PI(3,5)P₂
• Phosphatidylinositol 4,5-bisphosphate, also known as PtdIns(4,5)P₂, PI(4,5)P₂ or often simply referred to as PIP₂

Phosphatidylinositol trisphosphate:

• Phosphatidylinositol 3,4,5-trisphosphate, also known as PtdIns(3,4,5)P₃ or PI(3,4,5)P₃

These phosphoinositides are also found in plant cells, with the exception of PIP₃.

The significance of phosphatidylinositol (PI) metabolism lies in its role as a potential transducing mechanism, evident from studies showing hormone and neurotransmitter-induced hydrolysis of PI. The hydrolysis starts with the enzyme PI 4-kinase alpha (PI4Kα) converting PI into PI 4-phosphate (PI4P), which is then converted into PI (4,5) biphosphate (PI(4,5)P₂) by the enzyme PI 4-phosphate-5-kinase (PI4P5K). PI(4,5)P₂ is then hydrolysed by phospholipase C (PLC) and forms the second messengers, inositol (1,4,5) triphosphate (IP₃) and diacylglycerol (DG). DG is then phosphyrylated to phosphatidic acid (PA) by DG kinase (DGK). PA is also directly produced from phosphatidylcholine (PC) by phospholipase D (PLD). Lipid transfer proteins facilitate the exchange of PI and PA between membranes, ensuring its availability for receptor mechanisms on the plasma membrane, even in organelles like mitochondria incapable of PI synthesis.

 

The synthesis of Phosphatidylinositol (PI) is limited to the Endoplasmatic Reticulum (ER), which is the largest membrane componement of the cell. This site also contributes the synthesis to the majority of phospholipids, namely phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS) and triacylglycerol (TG). The synthesis involves a series of enzymatic reactions.

The biosynthesis and phosphorylation of PI is mainly confined to the cytosolic facing surface of organelles by already residential kinases, but not at the ER spesifically. De novo PI synthesis of PI starts with an acylated process of Glyceraldehyde-3-phosphate (G-3-P) by GPAT enzymes at the sn-1 acyl chain position. The process is then followed by a second acylation with LPAAT1, LPAAT2 and LPAAT3, LPAAT enzymes, at the sn-2 acyl chain position. This double step process acylates G-3-P to phosphatidic acid (PA).

PA is converted into the intermediate CDP- diacylglycerol (CDP-DG) by a process called CDP-diaglycerol synthase. This synthesis is catalyzed by the use of CDS1 and CDS2, CDS- enzymes. In the final enzymatic process, CDP-DG and inositol are catalyzed by the enzyme PI synthase (PIS) and synthesised into PI.

• Phosphatidylinositols at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
• Phosphatidylinositol at Lipid Library